Nationwide Fund Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-793,710
| Closed | -$28.9M | – | 680 |
|
|
2017
Q3 | $28.9M | Sell |
793,710
-15,513
| -2% | -$565K | 0.11% | 185 |
|
|
2017
Q2 | $31.9M | Sell |
809,223
-369,288
| -31% | -$14.6M | 0.13% | 164 |
|
|
2017
Q1 | $37M | Sell |
1,178,511
-86,586
| -7% | -$2.72M | 0.15% | 128 |
|
|
2016
Q4 | $39.5M | Buy |
1,265,097
+548,676
| +77% | +$17.1M | 0.16% | 105 |
|
|
2016
Q3 | $28.8M | Buy |
716,421
+3
| +0% | +$121 | 0.12% | 178 |
|
|
2016
Q2 | $23.8M | Sell |
716,418
-204,372
| -22% | -$6.79M | 0.1% | 221 |
|
|
2016
Q1 | $26.6M | Sell |
920,790
-13,476
| -1% | -$390K | 0.12% | 194 |
|
|
2015
Q4 | $24.6M | Buy |
934,266
+274,980
| +42% | +$7.24M | 0.11% | 224 |
|
|
2015
Q3 | $15.6M | Buy |
659,286
+277,536
| +73% | +$6.58M | 0.07% | 344 |
|
|
2015
Q2 | $9.06M | Buy |
381,750
+26,550
| +7% | +$630K | 0.04% | 632 |
|
|
2015
Q1 | $8.43M | Buy |
355,200
+153,864
| +76% | +$3.65M | 0.03% | 711 |
|
|
2014
Q4 | $4.27M | Buy |
201,336
+5,736
| +3% | +$122K | 0.02% | 1024 |
|
|
2014
Q3 | $3.33M | Sell |
195,600
-3,864
| -2% | -$65.8K | 0.01% | 1167 |
|
|
2014
Q2 | $2.85M | Sell |
199,464
-18,312
| -8% | -$262K | 0.01% | 1274 |
|
|
2014
Q1 | $2.69M | Sell |
217,776
-5,184
| -2% | -$64.1K | 0.01% | 1191 |
|
|
2013
Q4 | $2.44M | Sell |
222,960
-1,346,502
| -86% | -$14.8M | 0.01% | 1354 |
|
|
2013
Q3 | $18.2M | Buy |
1,569,462
+1,313,322
| +513% | +$15.2M | 0.08% | 288 |
|
|
2013
Q2 | $2.87M | Buy |
+256,140
| New | +$2.87M | 0.02% | 1103 |
|